How Do Nanoparticles Work in Immunosuppressive Therapies?
Nanoparticles can be engineered to deliver immunosuppressive drugs directly to specific cells or tissues, minimizing systemic side effects. These particles can be designed to target immune cells such as T-cells or dendritic cells, which play a pivotal role in initiating and sustaining immune responses. By delivering drugs like cyclosporine or tacrolimus directly to these cells, nanoparticles can enhance the efficacy of immunosuppression while reducing toxicity.
